The affected products are Saxenda (liraglutide), Wegovy (semaglutide), and Zepbound (tirzepatide)
Research reference: dosage ranges used in studies Scientific literature evaluating IGF-1 LR3 has explored a range of quantities and administration schedules depending on research objectives related to muscle hypertrophy, recovery, endurance, and metabolic health
United States: Elsevier (2012)
LifeMD remains dedicated to expanding access to high-quality, affordable weight management care, and the addition of Foundayo to our platform furthers that commitment." The addition of Foundayo expands LifeMD's offerings of branded GLP-1 therapies from both Lilly and Novo Nordisk and reinforces LifeMD's position as a leading destination for clinically guided weight management care with FDA-approved medications
HYGIENE A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS A61P3/00Drugs for disorders of the metabolism A61P3/02Nutrients, e.g